TY - JOUR
T1 - Differences in sensitivity to melphalan between Con A-activated and nonactivated human T-cell subsets
AU - Komlos, Luise
AU - Ben-Efraim, Shlomo
AU - Notmann, Jaffa
AU - Hart, Jacob
AU - Halbrecht, Isaac
PY - 1987/10
Y1 - 1987/10
N2 - In vitro treatment with melphalan (l-PAM, l-phenylalanine mustard), 2 μg 2 × 106 cells, significantly decreased the total number of E-rosette-positive (E+) T lymphocytes from peripheral blood (PBL) of healthy human donors as well as those of the OKT4 (precursor suppressor/helper/inducer T cells) and OKT17 populations (suppressor cells within the OKT4 subset). The OKT8 population (cytotoxic/mature suppressor cells) was not affected by a similar l-PAM treatment. The sensitivity of concanavalin A (Con A)-activated E+ T-cell populations to subsequent l-PAM treatment in vitro was different from that of Con A-untreated T cells: Thus, l-PAM treatment did not affect the expression of OKT3 and OKT4 antigens, increased the percentage of OKT17 cells, and inhibited the experssion of OKT8 antigen. Depletion of OKT8 from Con A-activated E+ T cells (OKT4+-OKT8--OKT17+) did not affect their suppressive activity on PHA stimulation in l-PAM-treated as well as untreated cells. Further depletion of OKT17+ cells from the OKT4+-OKT8--OKT17+ subset (OKT4+-OKT8--OKT17-) abolished the suppressive effect on PHA stimulation. Suppressive activity of the OKT4+-OKT8--OKT17- subset was again evident after treatment of this population with l-PAM. The results obtained indicate that the sensitivity to l-PAM treatment of various T-cell phenotypes is changed by Con A activation and that after depletion of specific T suppressor cells l-PAM seems to affect the immunoregulatory circuit within the Con A-activated OKT4 subset.
AB - In vitro treatment with melphalan (l-PAM, l-phenylalanine mustard), 2 μg 2 × 106 cells, significantly decreased the total number of E-rosette-positive (E+) T lymphocytes from peripheral blood (PBL) of healthy human donors as well as those of the OKT4 (precursor suppressor/helper/inducer T cells) and OKT17 populations (suppressor cells within the OKT4 subset). The OKT8 population (cytotoxic/mature suppressor cells) was not affected by a similar l-PAM treatment. The sensitivity of concanavalin A (Con A)-activated E+ T-cell populations to subsequent l-PAM treatment in vitro was different from that of Con A-untreated T cells: Thus, l-PAM treatment did not affect the expression of OKT3 and OKT4 antigens, increased the percentage of OKT17 cells, and inhibited the experssion of OKT8 antigen. Depletion of OKT8 from Con A-activated E+ T cells (OKT4+-OKT8--OKT17+) did not affect their suppressive activity on PHA stimulation in l-PAM-treated as well as untreated cells. Further depletion of OKT17+ cells from the OKT4+-OKT8--OKT17+ subset (OKT4+-OKT8--OKT17-) abolished the suppressive effect on PHA stimulation. Suppressive activity of the OKT4+-OKT8--OKT17- subset was again evident after treatment of this population with l-PAM. The results obtained indicate that the sensitivity to l-PAM treatment of various T-cell phenotypes is changed by Con A activation and that after depletion of specific T suppressor cells l-PAM seems to affect the immunoregulatory circuit within the Con A-activated OKT4 subset.
UR - https://www.scopus.com/pages/publications/0023235953
U2 - 10.1016/0090-1229(87)90116-4
DO - 10.1016/0090-1229(87)90116-4
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0023235953
SN - 0090-1229
VL - 45
SP - 105
EP - 113
JO - Clinical Immunology and Immunopathology
JF - Clinical Immunology and Immunopathology
IS - 1
ER -